HEALWELL AI: HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
HEALWELL AI Inc. (TSX:AIDX, OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, roughly flat vs. $33.2 million in Q2-2025. Six-month revenue rose to $66.2 million from $41.2 million, driven by the Orion Health acquisition. Operating cash flow was $4.5 million positive. The company valued its indirect SpaceX stake at about CAD$23 million and targets ~10% Adjusted EBITDA margin by year-end.
How this was made
The 30-second read
Why it matters
Key trading takeaways are (1) operating cash flow improvement in H1 2026, (2) a stated 2026 Adjusted EBITDA margin target of about 10%, and (3) a liquidity catalyst tied to monetizing a SpaceX-related holding as lock-up expires. Offsetting factors include flat Q2 revenue YoY and lower Q2 Adjusted EBITDA versus the prior year period.
Market read
This is a company-specific interim results update with quantified cash-flow and margin guidance, plus a potential liquidity catalyst from monetizing a SpaceX-related stake.
What to watch
The SpaceX stake is indirect and subject to lock-up timing and valuation swings; investors may discount the monetization impact until proceeds are realized and reflected in liquidity metrics.
Background
HEALWELL AI (AIDX) released unaudited interim financial results for the quarter and six months ended June 30, 2026, referencing integration progress after its Orion Health acquisition and a plan to monetize an indirect SpaceX-related position.
Market effects
Reinforces the narrative that healthcare AI vendors can shift from project work to recurring enterprise subscriptions to improve cash generation.
Primarily relevant to Canadian-listed healthcare AI investors and OTC holders tracking TSX/OTCQX liquidity.
Limited direct global read-through, but the Orion Health cross-sell and SpaceX monetization angle may influence sentiment toward AI platform monetization strategies.
Counterpoint
The headline cash-flow improvement may be acquisition-driven, while Q2-2026 Adjusted EBITDA declines YoY and revenue is flat, suggesting sustainability of margins is not yet proven.
Key entities
- issuerHEALWELL AI Inc.
Reports Q2-2026 and H1 2026 financial results, cash-flow improvement, and a 2026 Adjusted EBITDA margin target, plus plans to monetize an indirect SpaceX position.
- customer/platformOrion Health
HEALWELL cross-sells SMART Search and SMART Summary into Orion’s global install base and attributes recurring subscription growth to integration.
- investmentSpaceX (indirect holding via xAI Corp.)
HEALWELL’s indirect interest is valued at about CAD$23M as of June 30, 2026, with monetization intended after lock-up expiry.
